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SYNTHESIS AND CONFORMATIONAL STUDIES OF VARIOUS AMIDES

Abstract

By Marcos Beltran-Sanchez
University of the Pacific
2019

In the past, aminocyclohexanol rings have been successfully utilized as pH-triggered
molecular switches in various trans-2-aminocyclohexanol derivatives. By changing the groups
on the amine nitrogen, these models provided a wide pH range in which a switch can occur. The
pH-induced switch of conformation was monitored by 1H-NMR spectroscopy. The models were
also incorporated into the bilayer membrane of liposome structures and tested for their ability to
disrupt their membrane upon their conformational flip induced by a decrease in pH.
In this work, the amide bond has been studied as a molecular switch and various amide
derivatives have been tested for their potential as lipid-like compounds that also exhibit a pHsensitive conformational flip. The conformational analysis of these compounds was achieved by
various NMR techniques and NMR acid-base titration studies were utilized to estimate the pKa of
a number of the compounds described.
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CHAPTER 1: INTRODUCTION

1.1 Targeted Drug Delivery
Drug delivery can be described as the method of delivering therapeutic drugs and other
pharmaceuticals to their site of action within an organism. In the case of drug delivery through
the use of nanocarriers, therapeutic drugs are encapsulated by small vesicles and protected against
degradation, thus greatly increasing their bioavailability.1 They can also potentially make their
way to the target tissues with more ease since the transport across certain membranes may be
streamlined through the use of such carriers.1
Targeted drug delivery describes an aim to deliver the drugs to the specific site of action
whilst also minimalizing nonspecific side effects.2 In the past, a number of targeted drug delivery
systems have been developed and tested for the treatment of a variety of inflammatory diseases.
A number of the drug delivery systems that have been described in the past revolve around the
idea of using a liposome-like structure as an efficient drug carrier that can travel throughout the
body while suppressing the detrimental effects of macrophages and protecting sensitive tissues
from the potentially toxic drugs being transported.
Liposomes are spherical vesicles that are comprised of one or more bilayer membranes,
which are typically formed by natural non-toxic lipid molecules. The structure of these molecules
consists of a hydrophilic head region and a hydrophobic tail region, and the bilayer membrane is
formed by hydrophobic effects which force the tail regions of various molecules to come together.
This forms a spherical structure that has the hydrophilic heads facing towards the exterior of the
liposome, allowing it to survive in an aqueous environment, and towards the interior of the
liposome, allowing it to encapsulate aqueous solutions of the desired drugs3 (Figure 1).
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Figure 1. Formation of liposomes and how they can encapsulate drugs of interest

In 2001, Richards et al. studied how small liposomes could act as carriers for the delivery
of clodronate to tissues affected by rheumatoid arthritis in rats.4 The use of polyethylene glycolbased (PEG) liposomes to effectively deliver drugs for the treatment of multiple sclerosis has also
been examined in the past.5–7 In addition, such liposomal nanocarriers have been tested as drug
delivery systems to treat against uveitis,8,9 which is a form of eye inflammation, and colitis,10 which
is the inflammation of the colon.
Undoubtedly, the most attractive aspect of such drug delivery systems is their potential use
in specifically targeting cancerous tissues. One of the major challenges in successfully treating
diseases such as cancer is the ability to eradicate it while avoiding side effects that cause damage
to normal tissues. In other words, the issue is not a lack of drugs or treatment options, but instead
the lack of accurate and reliable targeted drug delivery methods.
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1.2 Conformational Molecular Switches
Conformational switches are molecular devices designed to induce a conformational
change in response to external stimuli such as certain ions, wavelengths of light, or pH values.11–
13

These devices are of great chemical importance because the functionality of a molecule is

usually highly dependent on its structure, therefore induced changes in conformation can have
significant effects. A few examples of how molecular switches can be used are: to alter the
chirality of molecules, to activate and/or deactivate fluorescence, and to control supramolecular
organization and assembly.14 In recent years, these switches have been used in a variety of
applications including information storage and transmission, fluorescence studies, and drug
release.15–18
The incorporation of molecular devices can be very advantageous in the design of targeted
drug delivery vesicles since certain diseases have been found to alter local physiological conditions,
such as pH levels, which can act as external triggers for a drug discharge. In the case of cancer,
researchers have discovered that the pH of the extracellular fluid surrounding tumor cells is lower
than that surrounding normal cells.19 Additionally, inflammation caused by conditions such as
ischemia, rheumatoid arthritis, and even asthma has also been reported to lower the pH of affected
tissues.20 With the proper molecular switch mechanism, these relatively acidic conditions may be
utilized for the specific targeting of such tissues as described further.
1.3 Flipids
In the past, molecular switches have been incorporated into drug delivery vesicles such as
modified liposomes.21–24 Liposomes are structures comprised of lipids, which are molecules
comprised of a polar, hydrophilic head region connected to nonpolar, hydrophobic tails.25 The
inclusion of a molecular switch to the head group of a lipid-like structure makes it possible to
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induce a conformational change that can flip the tails from a “closed” position, where the tails are
on the same side of the polar head, to an “open” position where the tails are apart (Figure 2).

Figure 2. Conformational flip of a lipid molecule

If these flippable lipid molecules or “flipids”23,24 are incorporated into the lipid bilayer
membrane of a liposomal structure, they can induce the rupture of the membrane due to the drastic
conformational switch. Additionally, if these spherical structures are pre-loaded with a therapeutic
drug, an efficient drug delivery system can be designed that will allow more control over the
release of the drug upon being triggered by the external stimulus (Figure 3).

Figure 3. Liposomal drug delivery facilitated by a molecular switch
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1.4 Cyclohexanol-Based Flipid Model
In previous years, the synthesis and characterization of conformationally-flipping liposome
structures, or “fliposomes”, has been successfully achieved in the Samoshin lab using trans-2aminocyclohexanol-based flipids.23,24 Those trans-2-aminocyclohexanol (TACH) flipid molecules
(Figure 4) consisted of long alkyl chains functioning as nonpolar tails linked to the cyclohexanol
ring by ester linkages. On the other end of the ring, which acts as the polar head, are the hydroxyl
group and an amino group vicinal to each other and both predominantly in the axial position. In
this conformation A, the alkyl chains are equatorially oriented and parallel to each other. Upon
protonation of the tertiary amine, however, a hydrogen bond forms between the protonated
nitrogen and the oxygen atom from the vicinal hydroxyl group. This favorable interaction draws
the two groups closer together, forcing them into equatorial positions, which in turn produces an
allosteric effect causing the entire ring to flip and forces the tails into the axial positions, disrupting
their parallel orientation and giving conformation B (Figure 4).

Figure 4. Shift in conformational equilibrium produced by protonation of a TACH flipid
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In this case, the substituted trans-2-aminocyclohexanol ring is a molecular switch that
induces a conformational change in the presence of acid. It works well because it has two stable
chair conformations but is initially biased towards conformation A by the sterically demanding
ester groups preferring to be equatorial. These flipids were synthesized and incorporated into the
membrane of a liposome structure which was successfully ruptured by the induced conformational
switch under acidic conditions, allowing the release of liposomal contents.
1.5 Novel Amide-Based Flipid Model
The aim of this project was to synthesize and characterize a series of compounds that
utilized a simpler flipid design which potentially may allow for more variability of the structure
whilst avoiding complex and potentially expensive synthetic processes. Any lipid model by
definition includes a polar head group and nonpolar tails. However, in an effort to incorporate the
switching mechanism utilized in the cyclohexanol-based flipid model, a tertiary amine is included
in the structure to trigger the conformational switch in the presence of acid as a hydrogen bond
donor. Additionally, the polar head region must: (1) include a hydrogen bond acceptor, (2) form
a bridge to connect the two tails.
The typical amide functional group consists of a nitrogen atom covalently bound to a
carbonyl group. Although nitrogen atoms can typically be protonated and make good hydrogen
bond donors in amines, the resonance delocalization of the lone pair makes it much less basic
(Figure 5). Instead, the carbonyl oxygen can function as a hydrogen bond acceptor.
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Figure 5. Resonance stabilization of the C—N amide bond

Moreover, if one nonpolar tail is connected to the carbon atom on one side of the C—N
bond and the second tail is connected to the nitrogen atom on the other side, the amide group will
effectively be a relatively polar group that connects both tails together, and also includes a
hydrogen bond acceptor. Therefore, a molecule with these structural components should resemble
a flipid structure that can interconvert between a syn form (closed flipid) where the two tails are
on the same side of the amide bond and an anti form (open flipid) where the tails are on opposite
sides of the bond (Figure 6).

Figure 6. General structure for the syn and anti isomers of an amide-based flipid molecule

Amides are quite unique in that the C—N bond has a partial double-bond character, as
depicted previously in Figure 5, that restricts rotation around it. To give an idea of the relative
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amount of energy required, the rotational barrier around the C—C bond of ethane is about 3
kcal/mol,26 the barrier around the C—N bond of dimethylacetamide is about 15 kcal/mol,27 and
the barrier around the C=C bond of 2-butene is about 39 kcal/mol.28 Therefore, there is no free
rotation around the amide bond as is typical in single bonds, but the rotation is also not completely
restricted as is the case with double bonds. It is hypothesized that the rotation is restricted enough
to allow for the molecule to be locked into an initial conformation that is stabilized by lipophilic
interactions in the lipid bilayer of the membrane, but not so restrictive that it is impossible to
overcome the rotational barrier and induce a conformational change as a function of a second
favorable interaction, e.g. the formation of a hydrogen bond.
1.6 Studying Aryl Amide Compounds
One of the general model structures that are of interest consists of aromatic rings attached
to either side of the amide bond since several studies of such structures have been reported in
recent years.29–31 For example, in 2017 Szostak et al. reported the resonance energies for a range
of anilides31 (Figure 7).

Figure 7. General structures for the syn and anti isomers of anilides
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According to the report, the resonance energies were calculated using the Carbonyl
Substitution Nitrogen Atom Replacement (COSNAR) computational method and further
optimized using DFT and ab initio methods. The calculated values suggest that these anilide
molecules “feature a significantly decreased barrier to rotation around the amide N—C bond.”31
These results posed new questions about these aromatic ring structures and inspired one of
the projects discussed later in this thesis in which a series of anilide compounds were synthesized
and their conformations were analyzed using various 1H-NMR techniques including Nuclear
Overhauser Effect Spectroscopy (NOESY).
1.7 The Nuclear Overhauser Effect
Nuclear Overhauser Effect Spectroscopy (NOESY) is an NMR technique that revolves
around the observation and measurement of signals produced by the Nuclear Overhauser Effect,
which is also known as the Nuclear Overhauser Enhancement because it enhances the integrated
intensity of NMR signals. This can be best explained by considering an example involving two
nuclei, X and Y, which local magnetic fields are influenced by each other’s through an
intramolecular dipole-dipole interaction. The intensity of the signal for X can be enhanced by
saturating the Y nuclei, which can be achieved by irradiating at the resonance frequency of Y. The
technique involves nuclear cross-relaxation processes, and since “the relaxation is very strongly
dependent on the distance between a pair of nuclei,”32 it is possible to observe responses from
nuclei that are in the same three-dimensional space but not necessarily spin-spin coupled. In other
words, it measures the signals of nuclei, such as protons, that are in close spatial proximity of each
other on time average, even if they are not directly connected through chemical bonds. It is an
extremely useful technique that was predicted to be “of considerable stereochemical and
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conformational interest in organic chemistry” back in 1965 by the researchers who reported the
first proton intramolecular NOE, Anet and Bourn.32
One example of how this technique has been used to distinguish between two isomers was
reported by Nouls, van Binst, and Martin in 1967.33 They reported the confirmation of the
geometrical assignment for the two isomers of 3-ethylidenel-azabicyclo[2.2.2]octane (Figure 8).

Figure 8. Molecular structures of the isomers of 3-ethylidenel-azabicyclo[2.2.2]octane

The two isomers are very similar to each other, the only difference being that in one isomer
the methyl group attached to the double bond is cis with respect to the C4—H bond, and trans in
the other. A mixture of the two in solution was analyzed by NMR and the proton on carbon-4
actually produced two distinct signals in the spectrum which corresponded to the two isomers.
The protons on carbon-10 also gave distinct signals. However, it was unclear which set of signals
corresponded to which isomers. NOE studies allowed for the correct determination of the signals
since isomer A exhibited a clear NOE between the protons on carbon-10 and the proton on carbon4 (shown as a red arrow), while isomer B showed no such effect due to the larger distance between
the two sets of protons.33
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More recently, the conformation of N-aryl-N-6-(azulenyl)acetamides was determined
through NOE studies conducted by Okamoto et al.34 An example of one of the structures analyzed
by the Okamoto group is shown in Figure 9. They were able to determine the conformation of the
molecule by irradiating at the resonance frequency of the protons on the methyl group attached
directly to the carbonyl group of the amide bond.

Figure 9. NOE signals produced by the two conformational isomers of N-phenyl-N-6(azulenyl)acetamide

By being able to observe whether an NOE signal was produced by either the protons
from the N-phenyl ring or the N-6-azulenyl ring, the researchers were able to reliably determine
whether the molecule was in the A or B conformation.
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CHAPTER 2: RESEARCH GOALS

The goal of this project was the development and examination of the pH-sensitive amidebased flipids and their potential for liposomal drug delivery. The research aims were:
1) Design and synthesis of a series of novel amide-based flipid molecules;
2) Study of conformational equilibrium of amide-based flipid molecules based on various 1HNMR techniques;
3) Study of pH-sensitivity of amide-based flipids and how it is affected by varying the amine
moieties in the hydrophobic tails;
4) Evaluation of the amide-based flipids for their potential use in liposomal targeted drug delivery
systems.
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CHAPTER 3: RESULTS AND DISCUSSION

3.1 Amide Flipid Model with Alkyl Chain Tails
The initial design for a new flipid model includes: an amide bond that acts as a molecular
switch, the two alkyl chain nonpolar tails, and a nitrogen atom embedded into one of the tails that
is exactly five atoms away from the carbonyl oxygen in order to be able to form a stable hydrogen
bond upon protonation (Figure 10). This amide flipid model with alkyl chain tails, N-(2(hexyl(methyl)amino)ethyl)-N-methyldecanamide, will henceforth be referred to as compound I.

Figure 10. Shift in conformational equilibrium produced by protonation of compound I

3.1.1 Synthesis of N-(2-(hexyl(methyl)amino)ethyl)-N-methyldecanamide (I)
An amide flipid model with alkyl chains as hydrophobic tails was successfully synthesized
(Scheme 1) by first sulfonating the hydroxyl group of 1-hexanol with p-toluenesulfonyl chloride
in order to convert the alcohol moiety into a good leaving group.
ethanediamine

was

then

used

to

nucleophilically

attack

the

N,N'-Dimethyl-1,2obtained

hexyl

4-
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methylbenzenesulfonate (II) in the presence of a base to afford N-hexyl-N,N’-dimethylethane-1,2diamine (III) (Scheme 1).
Finally, the target compound (I) was formed by reacting the diamine (III) produced from
the previous reaction with decanoic anhydride in the presence of the base triethylamine. The amine
attacked one of the carbonyl carbon atoms of the anhydride, releasing decanoic acid which was
neutralized by triethylamine, and ultimately produced N-(2-(hexyl(methyl)amino)ethyl)-Nmethyldecanamide (I) (Scheme 1).

The product was successfully purified by column

chromatography and its structure was confirmed by a combination of Nuclear Magnetic Resonance
(NMR) spectroscopy and high-resolution mass spectrometry (HRMS).

Scheme 1. Synthesis of compound I
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3.1.2 Conformational Analysis of N-(2-(hexyl(methyl)amino)ethyl)-N-methyldecanamide (I)
Due to the restricted rotation around the C—N amide bond, the interconversion between
the two conformational isomers of compound I (Figure 11) was expected to occur slowly enough
so that they appear as separate sets of signals on an NMR spectrum. This was confirmed when the
1

H-NMR spectrum revealed double sets of peaks which, through the use of NMR techniques such

as 2D-COSY and 2D-HMQC, were shown to correspond to the same group of protons. For
example, although one singlet peak is expected to be produced by each of the two methyl groups
in compound I, two singlets were observed for the (CH3NC=O) methyl group protons and a doublet
was observed for the (CH3N) methyl group protons (Figure 12). The appearance of these peaks
indicates that one pair of signals must correspond to the methyl groups in the syn conformation of
the compound, while the other corresponds to those of the anti conformation.

Figure 11. Equilibrium between the two conformers of compound I
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Figure 12. Observable separation of methyl group peaks of compound I (CH3NC=O methyl
group proton signals circled in red, CH3N methyl group proton signals circled in blue)

In addition, one pair of signals appeared more intense than the other in about a two-to-one
integration ratio. This is most clearly demonstrated by the peaks produced by the protons on the
methyl group directly attached to the amide nitrogen atom (Figure 13). Due to the reasons outlined
in the following paragraphs, the more intense signal was expected to belong to the methyl group
when it is in the anti conformation, and the smaller signal was expected to belong to that in the syn
conformation.

This determination was later supported by various NMR studies which are

described in more detail below.
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Figure 13. Section of a 1H-NMR spectrum illustrating the separation of the CH3NC=O methyl
group signals

The anti conformation was expected to produce the more intense signal in Figure 13 for a
couple of reasons. First, the proximity between the two tails in the syn conformation causes them
to repel each other and promote a shift in equilibrium to the anti isomer. In other words, the
increased electrostatic and steric interactions in the crowded syn conformation cause the molecule
to prefer to be in the anti conformation for longer periods of time. Second, the dipole moment
across the amide bond35 (Figure 14) depicts a partial positive charge on one side of the bond and
a partially negative charge on the opposite side. The partially negative region has higher electron
density at any given time, which produces a shielding effect on the surrounding protons.36 In the
anti conformation, the amide N-methyl group is directly on the positive end of the dipole, therefore
the signal is expected to be less shielded and appear more downfield in the NMR spectrum. In the

34
syn conformation, the same N-methyl group is further from the positive end, so the signal is
expected to be more upfield. Similar N-methyl group 1H-NMR assignments have been made in
the past for N-monosubstituted amides.37

Figure 14. Equilibrium between the two conformers of compound I depicted with dipoles

In order to test this hypothesis, the NMR sample solution was titrated with small portions
of a deuterated trifluoroacetic acid (d-TFA) solution in deuterated methanol (d-MeOH) and
continuously monitored by 1H-NMR spectroscopy. As expected, the integration values of one set
of signals became higher as a function of increased acid concentration while the other set of signals
became accordingly smaller (Figure 15). This data suggests that one of the conformations of the
flipid becomes more prevalent in solution as the pH lowers, as should be expected of the anti
conformation.

35

Figure 15. Effect of titrating compound I with d-TFA in a d-MeOH solution (ppm scales have
been shifted to better show the different signals)

The integration values of the anti N-methyl peak (labelled T in Figure 13) and syn Nmethyl peak (labelled C in Figure 13) were measured at each point of the titration to calculate the
percentages of the two conformations present in solution. In order to best illustrate the effect of
the addition of d-TFA, the percentage of the anti conformation present was plotted as a function
of pH in Figure 16. The rest of the data from the titration of compound I can also be found below
in Table 1 (also available in the Appendix).
The samples were titrated by adding small volumes of a 1.0 mM solution of deuterated
trifluoroacetic acid (d-TFA) in d-MeOH using micropipettes, and the pH (in this case pD) was
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measured once before running the sample in the NMR instrument and again after removing it from
the instrument in order to calculate an average value. These values coincided within 0.1 units.

Compound I Titration
95.0%
90.0%
85.0%
80.0%
75.0%
70.0%
65.0%

% anti conformation

100.0%

60.0%
9.00

8.00

7.00

6.00

5.00

4.00

3.00

2.00

pH
Figure 16. Graph depicting the percentage of the anti conformation of compound I present as a
function of pH

Table 1
Titration Data for Compound I
TFA* Total TFA:Flipid Average
T
C
Added TFA*
Molar
pH
(3.062ppm) (2.925ppm)
(µL)
(µL)
Ratio
0.00
0.00
0.0 : 1.0
8.22
1.95
0.99
7.00
7.00
0.2 : 1.0
8.07
1.92
0.97
10.00
17.00
0.5 : 1.0
7.89
2.01
0.90
7.00
24.00
0.7 : 1.0
7.74
2.04
0.88
7.00
31.00
0.9 : 1.0
7.65
2.07
0.87
10.00
41.00
1.2 : 1.0
7.60
2.12
0.81
14.00
55.00
1.6 : 1.0
7.42
2.20
0.73
14.00
69.00
2.0 : 1.0
7.14
2.31
0.62
14.00
83.00
2.5 : 1.0
6.73
2.57
0.36
14.00
97.00
2.9 : 1.0
5.82
2.80
0.13
14.00 111.00
3.3 : 1.0
2.80
2.83
0.10
*

% anti

66.3%
66.4%
69.1%
69.9%
70.4%
72.4%
75.1%
78.8%
87.7%
95.6%
96.6%

TFA refers to a 1.0 mM solution of deuterated TFA in d-MeOH
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These findings suggest that an interconversion is occurring between the syn and anti
isomers of the molecule in solution, and that this is happening slowly enough for the two
conformations to be captured as separate signals in the proton NMR spectrum.

If the

interconversion were occurring too quickly for the NMR timescale to capture, then only one
average set of peaks would be observed.36 The fact that it occurs slowly is a result of the relatively
high rotational barrier that restricts the rotation around the C—N amide bond.
However, the 1H-NMR spectrum shown in Figure 13 which was produced before the
addition of acid also shows a slight predominance of the anti conformation. This result is
undesirable since an ideal flipid should have a predominance of the syn isomer in solution before
the addition of acid in order to be able to make a large and significant conformational shift to the
anti isomer. A significant shift from the amount of syn isomer to anti isomer is expected to have
a large impact on the bilayer membrane of a fliposome structure and would thus be more likely to
cause the membrane to rupture and allow the fliposome to release its contents. Therefore, the fact
that the molecule already prefers the anti conformation is problematic.
3.2 Preparation of Liposomes
After synthesizing the pH-sensitive flipid model, it was incorporated into the bilayer
membrane of a liposome and tested to see whether the induced conformational change would be
enough

to

rupture

the

membrane

and

release

the

contents

within

the

acidic

environment/surroundings. Liposome preparation was commenced by mixing together the model
compound I along with 1-pamlitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), which is a
phospholipid known to be able to form a liposome structure.

N-palmitoyl-sphingosine-1-

(succinyl[methoxy(polyethylene glycol)2000]) (C16 PEG2000 Ceramide) was also added to the
mixture to form a coating around the membrane for steric stabilization of the liposome which
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results in an extended half-life in blood circulation.38 Four sets of liposomes were prepared by
mixing POPC, compound I, and PEG Ceramide in molar ratios of 70:25:5, 45:50:5, 20:75:5, and
0:95:5 with agitation in a pH 8.5 aqueous solution of 50mM ANTS/DPX, 5 mM HEPES buffer,
and 145 mM sodium chloride. The suspensions produced were frozen in -80 ºC EtOAc/liquid
nitrogen bath and then allowed to thaw and reach room temperature. This freeze/thaw cycle was
repeated nine times in order to allow the components to come together into proper liposome
structures through hydrophobic interactions. These liposome suspensions were subsequently
extruded ten times through polycarbonate membranes with 200 nm diameter pores to yield a
homogeneous liposome formulation, and then run on a Sephadex column using a 5mM HEPES
buffer (pH 8.5) to obtain a suspension of the liposomes free of any ANTS/DPX. At this point, any
ANTS/DPX present should be fully encapsulated by the liposome structures. The average sizes
and size distributions of the liposomes were then determined by Dynamic Light Scattering (DLS)
studies (See Table 2). A narrow size distribution is most desirable and is indicated by a low
Polydispersity Index (PdI) value.

Table 2
Dynamic Light Scattering Data of the Different Liposome Formulations
POPC : Compound I : PEG* Temperature Average Polydispersity
Molar Ratio
(ºC)
Size
Index
(nm)
(PdI)
70 : 25 : 5 after extrusion
25.0
120.4
0.134
45 : 50 : 5 after extrusion
25.0
125.2
0.206
20 : 75 : 5 after extrusion
25.0
84.15
0.369
0 : 95 : 5 after extrusion
25.0
156.3
0.579
*
PEG refers to C16 PEG2000 Ceramide

ζ
potential
(mV)
-0.634
0.450
-1.01
10.1

As is evident in Table 2, the amount of compound I introduced into the liposome structure
results in the PdI values becoming larger, meaning that the size distribution of the liposomes
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becomes larger. This can be an indication that incorporating too much of a foreign compound into
the bilayer membrane can alter the stability of its formation. General trends can also be observed
for the average fliposome size and ζ potential. The average size of the fliposomes seems to
increase as the amount of POPC decreases which is likely due to POPC being able to form stable
and more tightly-packed structures than the compound I molecules. The ζ potential also seems to
increase as the amount of POPC decreases since POPC contributes to a negative charge on the
surface of the fliposome membrane. As the amount of POPC in the membrane decreases, the
charge becomes more positive. The only outlier that does not fit either of these trends is the 20 :
75 : 5 formulation. It is unclear why this set of data does not match the rest.
3.3 ANTS/DPX Liposome Leakage Assay
ANTS/DPX is a fluorophore/quencher pair and is one of the most frequently used marker
pairs in testing membrane leakage and/or membrane fusion of vesicles.39 In this case, it is used for
evaluating the ability of the model flipid to successfully perturb the liposome membrane in
response to changes in pH.
Once the liposomes are loaded with the solution, the restricted space inside the structures
forces the fluorophore (ANTS) and quencher (DPX) to interact with each other and quench any
fluorescence. Once this is achieved and the liposomes have been effectively extruded and purified
on the Sephadex column, 100 µL of each of the liposome preparations were transferred to a glass
vial and dissolved in 2.9 mL of pH 8.5 HEPES buffer (5 mM HEPES + 145 mM NaCl). A set of
samples were prepared for the four liposome formulations and were tested for fluorescence
separately in cuvettes containing 50 µL aliquots of the samples dissolved in 2 mL of pH 8.5 HEPES
buffer, an assay that has been previously described by Guo et al.40 and successfully employed
recently for studies of fliposomes.22,23,41,42 The liposomes are expected to not exhibit any
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fluorescence until the membrane has ruptured, which allows the release of ANTS and DPX. Once
these molecules are released into the surrounding solution and allowed to diffuse freely into the
solution, the fluorophore will no longer be quenched and fluorescence can be observed and
accurately measured. In order to measure what the 100% leakage would yield in terms of
fluorescence, 20 µL of the detergent octaethylene glycol mono-n-dodecyl ether, which is known
to fully disrupt any liposomal bilayer, were added to the samples at the end of each measurement.
When this assay was attempted for the synthesized liposomes, however, fluorescence was already
observed from the start before the addition of detergent. There was only a small increase in
fluorescence after the suspensions were treated with the detergent, which suggests that most of the
liposomes were likely already disrupted at the starting pH (Table 3).

Table 3
Fluorimetry Results for the Four Different Fliposome Formulations
POPC : Compound I : PEG*
pH
% Leakage before
Molar Ratio
addition of detergent
70 : 25 : 5
8.5
40
45 : 50 : 5
8.5
70
20 : 75 : 5
8.5
100
0 : 95 : 5
8.5
100
*
PEG refers to C16 PEG2000 Ceramide

Since the 70:25:5 and 45:50:5 fliposome formulations presented the most promising results,
new solutions of these formulations were prepared at different pH to study how this affected the
leakage. Two sets of three solutions were prepared by dissolving 100 µL of the liposome
preparations in 2.9 mL of pH 4.5 acetic acid buffer (50 mM AcOH/AcONa + 145 mM NaCl), pH
8.5 HEPES buffer (5 mM HEPES + 145 mM NaCl), and pH 10.6 HEPES buffer (5 mM HEPES +
145 mM NaCl). The fluorimetry results are presented below in Table 4.
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Table 4
The Effect of pH on the Fluorimetry Results
POPC : Compound I : PEG*
Molar Ratio

pH

% Leakage before
addition of detergent

70 : 25 : 5
10.6
33
70 : 25 : 5
8.5
41
70 : 25 : 5
4.5
52
45 : 50 : 5
10.6
74
45 : 50 : 5
8.5
76
45 : 50 : 5
4.5
81
*
PEG refers to C16 PEG2000 Ceramide

As expected, the amount of leakage measured by the fluorimetry assay increases as the pH
is lowered for both formulations. This supports our hypothesis that the lowering of pH can
promote the protonation of compound I, thus forcing it to shift into the anti conformation and
ultimately disrupting the bilayer membrane to induce the leakage of ANTS/DPX. However, all of
the samples produced significant leakage before the addition of detergent even at pH 10.6 and were
not able to achieve 100% leakage at a pH as low as 4.5. This suggests that the fliposomes are
already unstable at high pH and yet the flipid molecules are incapable of producing a disruption in
the bilayer membrane that is significant enough to completely rupture the structure.
3.4 Factors Affecting Liposomal Leakage
There are a few major factors that affect liposomal leakage and may be directly or partially
responsible for the results of the ANTS/DPX assay. These include the possibility of the tertiary
amine being too strong of a base because the pKa for the N,N'-Dimethylethylenediamine itself is
reported to be 10.16.43 This high basicity may prematurely promote the formation of a hydrogen
bond and force the switch to the anti conformation, as well as the possibility of the conformational
change being ineffective in drastically perturbing the membrane as previously predicted.
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3.4.1 Basicity of the Tertiary Amine
One factor that may affect liposomal leakage may be the basicity of the tertiary amine
embedded in one of the alkyl chain tails being too high. The previous 1H-NMR analysis of
compound I describes a situation in which the two conformers can be observed separately and the
amount of the anti conformation relative to the syn conformation becomes higher as more acid is
added. However, as shown previously in Figure 13 about 66% of compound I is estimated to be
anti before the addition of acid while the other 34% is syn. An increased basicity may be a
contributing factor for the abundance of the anti isomer.
The tertiary amine is responsible for the formation of the hydrogen bond that induces the
conformational change. Therefore, if too basic, it may be prematurely protonated in certain
solvents and result in the abundance of the anti conformation. Ideally, an initial high abundance
of the syn conformation is desirable in order to have a more drastic steric effect when acid is added.
3.4.2 Overall Steric Effect of the Conformational Flip
The two main components of compound I are the relatively polar head amide group and
the two alkyl chain tails. One major characteristic of saturated alkyl chains such as these is their
very high flexibility. The single bonds that connect the carbon atoms to each other are almost
freely rotating and when unhindered can result in a variety of shapes and types of movement for
the tails.
Lipids are generally tightly packed in the bilayer membrane by hydrophobic interactions
that cause the nonpolar tails to come together and shield themselves from the surrounding aqueous
environment. Because compound I previously demonstrated the ability to convert to the anti
conformation upon the addition of acid, it is speculated that the switch may be successfully
occurring within the membrane of the liposomes as well, but the steric effect is just not drastic
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enough to significantly disrupt and break the membrane apart. The decreased steric effect is
thought to be a consequence of the flexibility of the lipid tails that, even though a switch may occur,
are still able to keep the lipid bilayer together. This lack of rigidity is speculated to be able to
cause a decreased steric effect by allowing the tails to still be relatively proximal to each other
even after a successful conformational switch (Figure 17).

Figure 17. Conformational switch of compound I with decreased steric effect

Thus, the tails may have mostly remained embedded in the nonpolar region of the bilayer
membrane and the conformational change may have failed to cause a drastic enough effect to
disrupt the (now slightly less) efficient packing of the liposomal bilayer. Making the switch drastic
enough to force the nonpolar tails of the individual flipid molecules far apart and thus alter the
efficient packing of lipids in the bilayer membrane is not a trivial task.
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3.5 Amide Model with Aryl Rings
In order to test if the rigidity of a flipid structure has a significant steric effect on the
conformational flip, we synthesized a flipid model, N-methyl-N-(pyridin-2-yl)benzamide, that had
been described previously by Okamoto et al.30 and analyzed it by NMR. This model compound,
henceforth referred to as compound IV, also includes an amide bond as the molecular switch, but
instead of having long nonpolar alkyl chain tails, aromatic rings are directly attached to either side
of the C—N amide bond. One of these rings is simply a phenyl ring, which is attached to the
carbonyl carbon, while the other is a pyridine ring and is attached to the nitrogen atom of the amide
bond at the ortho position. This position is important because it allows the pyridine nitrogen atom
to be four bonds away from the carbonyl oxygen atom and form a six-membered ring structure
upon protonation and the formation of a hydrogen bond. (Figure 18).

Figure 18. Conformational switch of compound IV (hydrogen bond shown in blue)

Okamoto et al. reported that this compound exhibited different 1H-NMR peaks for the Nmethyl group protons in the syn and anti conformations, and that the shift from syn to anti upon
the addition of acid was monitorable by 1H-NMR.30 Therefore, we hypothesized that it may be
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possible to synthesize a series of similar aryl ring amide compounds by adding tails to the para or
meta positions of the aryl rings via ether linkages.
3.5.1 Synthesis of N-methyl-N-(pyridin-2-yl)benzamide (IV)
Compound IV was synthesized in a slightly different fashion from the previous alkyl chain
model (I). The reaction involved the nucleophilic substitution of benzoyl chloride with 2methylamino pyridine in the presence of a base. This resulted in the elimination of a chloride ion,
which abstracted a proton to form hydrochloric acid. This was neutralized by the base and
subsequently removed in the work-up steps. The product was successfully synthesized with a 33%
yield (Scheme 2) and its identity/structure confirmed by NMR spectroscopy and mass
spectrometry.

Scheme 2. Synthetic scheme for compound IV

3.5.2 Conformational Analysis of N-methyl-N-(pyridin-2-yl)benzamide (IV)
In accordance with compound I, we studied the conformation of compound IV by NMR
spectroscopy.

However, the 1H-NMR revealed only one set of proton signals in standard

conditions. This is most clearly elucidated by the single peak corresponding to the methyl group
in the structure (Figure 19).
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Figure 19. 1H-NMR spectrum in d-MeOH illustrating the lack of signal separation for the
individual conformations of compound IV

This lack of signal separation indicates that the switch or interconversion occurring
between the syn and anti conformations cannot be monitored by integration of signals in the NMR
spectrum in standard conditions. In an attempt to replicate the Okamoto results,30 varying amounts
of d-TFA were added to the NMR sample solution to see if a distinction between the two
conformations. However, contrary to what was previously reported,30 the only effect produced
was a shift in resonance frequency for the peak. Figure 20 clearly shows this phenomenon
occurring with the N-methyl group of compound IV.
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Figure 20. Effect of adding d-TFA to compound IV in d-TFA:IV molar ratios of 0.0:1.0 (1),
0.5:1.0 (2), 1.0:1.0 (3), and 50.0:1.0 (4)

One situation that may explain the lack of signal separation would be that the switch
between conformations is not occurring at all. The addition of aromatic rings to the structure may
have introduced some steric hindrance or more resonance-stabilization of the amide bond, both of
which could result in an increase in the energetic barrier for the rotation around the bond. This
unexpectedly high rotational barrier would prevent the conformational switching and would
instead cause the compound to remain frozen in either the syn or anti conformation.
However, because the reaction likely yields a mixture of isomers, then one would expect
the lack of interconversion to result in two distinguishable sets of signals in the 1H-NMR spectrum,
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especially for the methyl group protons because they are in quite different environments in the
different conformations. This explanation can therefore be disregarded.
Alternatively, a rapid interconversion between the two conformations could explain the
lack of separate signals. In this case, it may be that only one average set of signals would be
observed in the spectrum, analogous to the rapidly interconverting chair conformations of
cyclohexane.44 This is also supported by some data presented in the same Okamoto paper that
described the previous 1H-NMR analysis of compound IV. In the paper, the researchers present
the 1H-NMR spectrum of a compound similar to compound IV except both rings are pyridine rings
and the nitrogen atom on the amide bond is non-methylated. This compound also displayed a lack
of signal separation between the two conformations at standard conditions, but the Okamoto group
reported the successful separation of the conformations by performing variable temperature NMR
studies and lowering the temperature in the NMR instrument. As the temperature decreased the
signals became better separated and the distinction between conformations became increasingly
clear.30 This indicates that there was a rapid interconversion between conformations occurring for
that particular compound, which leads us to believe that this may also be the case for compound
IV.
3.6 NOE Studies
As mentioned in the introduction, NOESY is an NMR technique that can measure the
interaction between nuclear spins that are in the same three-dimensional space even in cases when
they are not directly connected through chemical bonds. It is very useful in the determination of
three-dimensional structures and we were able to utilize it to determine whether both syn and anti
conformations of the compound IV were present and rapidly interconverting in the solution.
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3.6.1 NOESY Results of N-methyl-N-(pyridin-2-yl)benzamide (IV)
As shown below in Figure 21, the HO protons are very close to the methyl group protons
when the molecule is in the anti conformation but are a great distance apart in the syn conformation.
Alternatively, the HO protons are very close to the H3 proton of the pyridine ring in the syn
conformation, but not in the anti. Therefore, a large NOE is expected to be observed for the HO
protons when irradiating the resonance frequency of the methyl group protons if the structure is in
the anti conformation, and vice versa. Conversely, a large NOE is expected to be observed for the
H3 protons by irradiating the resonance frequency of the HO proton peak if in the syn conformation.

Figure 21. Labeled chemical structures of compound IV in the anti and syn conformations

The first experiment was conducted by irradiating the N-methyl group signal. As expected
of the anti conformer, an NOE was observed for the HO proton signal (Figure 22).
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Figure 22. NOE produced upon irradiation of the N-methyl (CH3) signal

This result may mean that the molecule is locked into the anti conformation. However,
there may be a rapid interconversion occurring in solution because the presence of an NOE signal
does not negate the possibility of the syn conformer also being present. In order to test whether or
not the latter is occurring, the second experiment was conducted by irradiating the HO proton signal.
This resulted in the appearance of an NOE for the H3 proton and suggests that there is indeed a
rapid interconversion occurring between the two conformations (Figure 23).
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Figure 23. NOE produced upon irradiation of the HO signal

It is important to note that irradiation of the HO signal also produced an NOE for the methyl
group protons (CH3), again suggesting the presence of the anti conformation, but the signal
produced was much more intense than the NOE produced for the H3 proton. Although NOESY
does not provide any reliable quantitative information, it is reasonable that this clear difference in
NOE signal intensity suggests that although there seems to be a rapid interconversion occurring
between the two conformers, the amount of the anti conformer is still more prevalent in solution.
3.6.2 Disadvantages of NOESY
As mentioned previously, the major disadvantage of the NOESY technique is, arguably,
the inability to quantify the data presented in the spectra.

The intensities of the signals in the

spectra do not accurately reflect the distance between nuclei. Therefore, not only is it impossible
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to establish a syn:anti ratio for compound IV, the assumptions made regarding the prevalence of
one conformer over the other must be taken with a grain of salt. In order to get a better idea of just
how reliable and informative this technique is for this model, a series of additional NOESY
experiments were conducted with compounds of similar structure.
The first compound studied was the commercially available N-methylbenzamide (Figure
24). If the assumptions made for compound IV are correct, then one would expect that irradiation
of the signal for the protons on the ortho position of the phenyl ring (HO) would result in an NOE
from either the proton directly on the amide nitrogen atom (N-H) or the protons on the methyl
group (N-CH3). Both of these were observed, but also exhibited similar intensities. One would
expect a preference for the conformation in which the methyl group and phenyl ring are facing
away from each other (Figure 24), especially because it was reported that the N-methylation of the
amide nitrogen atom promoted stabilization of the syn conformation of similar aryl ring
compounds.45 The NOESY results obtained for compound IV contradict that idea.

Figure 24. Molecular isomeric structures of N-methylbenzamide

53
The commercially available N,N-Dimethylacetamide was also analyzed by NOESY
(Figure 25). This compound has been studied extensively in the past and it has been established
that there is a restricted rotation around the C—N bond.46,47 However, upon irradiation of C, we
observed NOE for both A and B at similar intensities. These observations indicate that at relatively
short distances both NOE and the through-bond interactions may produce similar results, thus
preventing the assignment of conformations.

Figure 25. Molecular structure of N,N-dimethylacetamide

Finally, the commercially available N-methyl-2-pyrrolidone (Figure 26) was also analyzed
in order to get a better idea of the NOE responses to be expected in the case of a conformationallylocked structure. For example, in this fixed ring structure, one would expect that the distance
between the N-methyl protons and the protons on the α-carbon would be too great to produce any
NOE between the two. However, irradiation of the α-carbon protons (shown in red) did produce
a signal from the N-methyl protons and vice versa thus practically reproducing the results for N,Ndimethylacetamide (see above).
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Figure 26. Molecular structure of N-methyl, 2-pyrrolidone

Therefore, the NOESY results obtained for Compound IV seem to be less reliable than
previously thought. It still seems likely that there is a rapid interconversion occurring between the
conformers, but it is unclear if there is a preference for one conformer over the other. The most
convenient and reliable method of accurately measuring the ratio between two conformers is to
compare the intensities of the signals from the separate isomers on a 1H-NMR spectrum, as was
done with compound I. In order to be able to do this, however, we sought a methodology to reduce
the speed of interconversion down to a level where the two conformers would provide
distinguishable signals in the 1H-NMR spectrum.
3.7 Exploring the Rotational Barriers of Similar Diaryl Compounds
3.7.1 Reported Rotational Barrier Trends of Anilide Compounds
The recently published computational study of a range of anilide compounds included
para-substituted derivatives similar to our models with various “electron-rich (NMe2, OMe, Me),
neutral (H), electron-withdrawing (NO2, CN, COMe, CF3), and halide (Br, Cl, F) substituents.31
In this study, the amidic resonance energies of these compounds were calculated and compared to
each other. Resonance energy is defined as the difference in potential energy between a molecule
of interest and the contributing resonance structure of the lowest potential energy.48 Therefore,
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molecules with higher resonance energies exhibit a decrease in the rate of rotation around the
amide bond. The Szostak results show a very interesting trend in which a significant decrease in
the resonance energy was calculated when the C-aryl ring was para-substituted with an electrondonating group (EDG) while the N-aryl ring was para-substituted with an electron withdrawing
group (EWG) (Figure 27). The opposite also holds true in that a significant increase in resonance
energy was calculated when electron withdrawing substituents were attached to the C-aryl ring
and electron-donating substituents to the N-aryl ring.

Figure 27. Anilide general structure with N-aryl ring (blue) and C-aryl ring (red)

Table 5 summarizes the calculated results of how much the resonance energy can be
affected by varying the electronic effects of the substituents on two aromatic rings. According to
the calculations, there should be about a 10 kcal/mol difference in the resonance energy between
the two extremes.
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Table 5
Calculated Resonance Energies for Various Anilide Compounds (Adapated From Szostak)31

R1
4-NO2
4-CN
4-MeO
4-NMe2

R2
4-NMe2
4-MeO
4-CN
4-NO2

Calc. Resonance Energies
8.8 kcal/mol
10.7 kcal/mol
17.5 kcal/mol
18.3 kcal/mol

Importantly, the idea that a rapid interconversion is occurring in solution for compound IV
is corroborated by these resonance energy calculations.
3.7.2 Synthesis of p-Substituted Anilide Compounds
One of the questions that arose from studying the anilide compounds was “Can these
increased rotational barriers restrict the rotation around the C—N bond enough to significantly
reduce the speed of the interconversion and produce two sets of signals on the 1H-NMR spectrum
as was observed with compound I?” The computational results31 (see above) predict this possibility.
In order to answer this question, we synthesized a series of four anilide compounds and analyzed
them by 1H-NMR spectroscopy. Two of the four compounds were inspired by some of the
compounds studied in the Szostak study and consisted of structures that had EWG’s on the C-aryl
rings and EDG’s on the N-aryl rings.
The rapid interconversion was only one of the issues that had to be addressed in order to
successfully synthesize a potential flipid molecule, however. Besides being able to observe
separate peaks on a 1H-NMR spectrum for more complete and quantifiable data, it is also
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imperative that the structure be initially locked in the syn conformation to accurately resemble a
lipid-like structure. The Szostak study reported that such structures actually preferred the anti
conformation due to the repulsion of the two large aromatic rings.31 On the other hand, as
previously mentioned, the N-methylation of the amide nitrogen atom has been reported to promote
stabilization of the syn conformation of similar compounds45 (Figure 28).

Figure 28. syn-Favored conformation of anilides upon N-methylation of amide nitrogen

Therefore, the next set of compounds was designed to test if: (1) the rapid interconversion
could be hindered by varying the electronic effects imposed by the aromatic rings on the amide
bond, and (2) if the inclusion or removal of the amide methyl group had any effect on either the
speed of interconversion or the initial conformational preference. The structure of the new set of
compounds is shown in Figure 29.
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Figure 29. Set of p-substituted anilide compounds synthesized for conformational analysis

These compounds were synthesized in a very similar manner to compound IV by acylation
of the amine nitrogen atom of p-anisidine, N,N-dimethyl-p-phenylenediamine, p-methoxy-Nmethylaniline, or N,N,N’-trimethylbenzene-1,4-diamine by p-nitrobenzoyl chloride in the
presence of excess base. The role of the base was to neutralize the hydrochloric acid that was
formed as a byproduct of the reaction. The products were successfully synthesized and confirmed
by NMR spectroscopy and mass spectrometry (Scheme 3).
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Scheme 3. General synthetic scheme for compounds V-VIII

3.7.3 Conformational Analysis of p-Substituted Anilide Compounds
All four of these compounds were first analyzed by 1H-NMR spectroscopy but,
unfortunately, none of them produced separate proton signals for the syn and anti isomers. Even
the structures calculated to have the highest increase in rotational barrier in the Sztosak study31
were unable to significantly decrease the speed of the interconversion between conformers to allow
for a separation of the NMR signals.
NOE studies were performed on these compounds and seemed to show that N-methylation
of the amide nitrogen atom may result in a noticeable amount of the syn conformation present in
solution.

Figure 30. Expected NOE response from proton C (in syn conformation)
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No NOE at all was observed from proton C after irradiation of the proton B signal (Figure
30) in the compounds VI and VIII that are non-N-methylated, which would suggest that the
molecules are entirely in the anti conformation. This supports what has been previously reported
by Okamoto et al.30 that the anti isomer is naturally more abundant and stable for such structures.
When the N-methylated compounds V and VII were analyzed by NOESY in the same
fashion, a small NOE was observed for proton C (Figure 31). Again, this result does not provide
any quantitative information but, qualitatively, it attests for a noticeable contribution of the syn
form to the equilibrium.

Figure 31. NOE results depicting the appearance of a response from proton C exclusively in the
N-methylated anilide compounds

3.8 Comparative Evaluation of the Alkyl Chains and Aryl Rings Models
Upon comparison between the alkyl chain and aryl ring amide switch model compounds,
it becomes evident that they behave quite differently but each have their advantages and
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disadvantages as a scaffold for potential flipid models. The alkyl chain model, compound I, is an
attractive candidate because it was shown to switch between the syn and anti conformations in
solution. More importantly, it allows for the direct observation of the separate conformers using
1

H-NMR spectroscopy. On the other hand, the prevalence of the anti conformation before any

addition of acid poses a problem and hinders the ability of the flipids to undergo a drastic enough
conformational change to significantly disrupt the membrane of a liposome to the point where it
releases the liposomal contents.
The aryl ring model, compound IV, displays an increased rigidity in the molecular structure
of a potential flipid, which should produce a much more pronounced steric effect upon switching
conformation. Unfortunately, the inability to observe the two conformers using 1H-NMR in
standard conditions severely minimizes the amount of available information and quantitative data
that is necessary to study the behavior of these molecules. In addition to this, there is still a problem
regarding the prevalence of the anti conformation before the addition of acid, likely caused by the
repulsion of the two large aryl rings being in such close proximity to each other in the syn
conformation.
Therefore, an intermediate model that can include both the ability to increase the rotational
barrier enough to distinguish separate isomers using 1H-NMR, and a relative increase in rigidity
from compound I is desirable. It is also necessary to reintroduce an amine of suitable pKa in the
structure in order to be able to produce flipid molecules that can actually induce a shift in
equilibrium to the anti conformation by forming a hydrogen bond lock upon addition of acid.
3.9 Hybrid Amide Flipid Model
Taking these desirable qualities into account, as well as the previous drawbacks, a new set
of amide-switch flipid molecules were synthesized and characterized. In order to regain the ability
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to monitor the equilibrium between conformations via 1H-NMR, and to eliminate the steric strain
produced by having two aryl rings intramolecularly repelling each other, one of the rings from
compound IV was replaced with a simple alkyl chain tail. Conversely, the other aromatic ring was
replaced with a heterocyclic nonaromatic amine that contains a nitrogen atom five bonds away
from the carbonyl oxygen atom of the amide moiety in order to be able to form a stable sevenmember ring structure upon protonation and formation of a hydrogen bond. The heterocyclic ring
was also not directly attached to the amide bond as was the case with compound IV but was instead
connected to the amide bond through a dimethylene bridge in order to produce a slightly more
elongated tail structure (Figure 32).

Figure 32. General structure and conformational switch for the hybrid model compounds
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3.9.1 Synthesis of the Hybrid Models
These alkyl chain/ring hybrid models were synthesized by reacting a carboxylic acid with
an amine to produce the amide bond. Decanoic acid was utilized as the carboxylic acid in order
to be able to have a relatively long nine-carbon chain tail, and the amine used was (N-methyl)aminoethanol in order to introduce the dimethylene bridge with the ethanol component. The
carboxylic acid is first activated via a halogenation reaction with oxalyl chloride to facilitate the
nucleophilic attack by the amine. Then, a nitrogen-containing heterocycle was attached to the
dimethylene bridge by first converting the hydroxy group of the ethanol moiety into a good leaving
group by tosylation and then allowing the heterocyclic ring to displace the tosyloxy group via
nucleophilic substitution (Scheme 4). The heterocyclic rings morpholine, piperidine, and Nmethylpiperazine were used to produce three different models, compounds XII, XIII, and XIV
respectively (Figure 33).
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Scheme 4. General synthetic scheme for compounds IX-XIV.
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Figure 33. Molecular structures for compounds XII – XIV

3.9.2 Conformational Analysis of the Hybrid Models
The three model compounds were successfully synthesized and analyzed by 1H-NMR
spectroscopy. Fortunately, it became immediately clear that one of the goals for these compounds
was achieved in that the 1H-NMR spectra for all three compounds showed two distinct sets of
signals, in particular the signals for the N-methyl protons on the separate conformers. In other
words, it was possible to directly observe and measure the ratio between the two conformations.
In addition, small consecutive additions of d-TFA to the NMR samples revealed that
lowering the pH of the solution effectively induced a shift in equilibrium to the anti conformation
(Figure 32). This strongly supports the idea that an equilibrium between conformations was
occurring in solution and that the heterocyclic rings were being protonated and inducing the
conformational switch.
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Unfortunately, the spectra also still revealed a preference for the anti conformation of the
three molecules even before the addition of acid. The removal of one of the ring structures from
the molecules, in combination with ensuring that the amide nitrogen atom was methylated and
reducing the steric strain around the amide bond by distancing the heterocyclic ring with a
dimethylene bridge, was evidently not enough to promote a complete shift in equilibrium to the
syn conformation as desirable.

The syn:anti ratios for the piperidine, morpholine, and N-

methylpiperazine models were all about 1 : 2. It may be possible that this continued preference
for the anti isomer was a result of some steric hindrance or repulsion between the two tails.
Despite this, the three model compounds were also tested for their pH-sensitivity by
subjecting them to acid-base titration studies. As was the case with the compound I titration results,
the signals for the anti conformation were expected to become more intense as more d-TFA is
added while the syn signals become less intense.
3.9.3 Acid-Base Titration Studies
The first compound that was titrated was compound XII. In consistency with the titration
of compound I, compound XII was dissolved in d-MeOH and treated with several small amounts
of a 1.0 mM solution of d-TFA in d-MeOH with intermittent analysis by 1H-NMR spectroscopy.
The separation of peaks for the two conformers is best illustrated by the proton signals for the Nmethyl group (See Figure 34).
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Figure 34. Portion of 1H-NMR spectrum for compound XII depicting the N-methyl group
protons in the two conformations before addition of acid

The results from the titration with d-TFA can be found below in Figure 35 where the
measured percentage of the anti conformation present in solution is plotted against the pD. The
percentage of the anti conformation (% anti) was estimated from the integration values of the
CH3N(C=O) group peaks in the 1H-NMR spectrum (Figure 34). The numerical data can be found
in Table 6 (See Appendix). As was observed with compound I, there is also an abundance of the
anti isomer of compound XII before the addition of acid. The addition of acid does promote a
further shift in equilibrium and seems to reach a maximum at around 93% anti conformation. This
illustrates that the switch is pD-sensitive.

68

Compound XII Titration
100.0%
95.0%

85.0%
80.0%
75.0%

% anti

90.0%

70.0%
65.0%
60.0%
10.00

9.00

8.00

7.00

6.00

5.00

4.00

3.00

2.00

1.00

0.00

pD

Figure 35. Percentage of the anti conformation of compound XII plotted as a function of pD

According the Henderson-Hasselbach equation, the concentration of the conjugate acid and
the base is equal when the pH is equal to the pKa.49 In other words, at this specific pH, or pD in
this case, half of the flipid molecules are protonated while the other half are not. Since the
protonated forms of the molecules are fully expected to be in the anti conformation and the titration
curve from Figure 35 represents a shift from the syn conformation to the anti conformation with
decrease of pD, the curve can also serve as a means to monitor the shift from non-protonated to
protonated molecules. Therefore, the midpoint of the curve serves as a good estimation for the
pKa50 of the conjugate acid of compound XII, which can also be referred to as the pKaH of
compound XII. The pKaH is thus estimated to be about 5.5.
The pKaH of morpholine has been reported to be 8.36,51 which indicates that the conjugate
acid of compound XII is about three orders of magnitude more acidic than the conjugate acid of
morpholine, also known as morpholinium. This increased acidity is expected since the pKaH of a
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secondary amine, morpholine, is being compared to the pKaH of a tertiary amine, compound XII.
This is also exemplified in Figure 36 when comparing morpholinium to N-ethylmorpholinium.

Figure 36. Comparison of the pKa values for morpholinium and N-ethylmorpholinium

Another factor that may contribute to this increased acidity may be the electronwithdrawing effect caused by the amide bond which is only two bonds away from the basic
nitrogen atom of the morpholine moiety in compound XII. A similar effect is seen between the
conjugate acid of piperidine, known as piperidinium, and morpholinium (Figure 37).
Morpholinium is much more acidic than piperidinium and the increased acidity of morpholinium
is largely due to the electron withdrawing effect of the oxygen atom located two bonds away from
the basic nitrogen atom.52

Figure 37. Reported pKa values for piperidinium and morpholinium51
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The next compound studied was compound XIII which contains a piperidine ring as the
heterocycle. The titration results for this compound can be seen in Figure 38 and Table 7 (See
Appendix).
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Figure 38. Percentage of the anti conformation of compound XIII as a function of pD

Evidently, compound XIII is considerably more acid-sensitive than compound XII. This
is to be expected since, as mentioned above, piperidine is much more basic than morpholine.
According to the titration curve shown in Figure 38, the pKaH for this compound is about 7.5. This
estimated pKaH value is higher than that estimated for compound XII, but it is also about three to
four orders of magnitude smaller than that of piperidine. This again indicates that the structure of
these compounds, namely the close proximity of the amide bond, significantly decreases the
basicity of the heterocyclic amine moieties.
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Finally, the N-methylpiperazine compound, compound XIV, was also titrated and the
results can be found below in Figure 39 and Table 8 (See Appendix). Interestingly, this compound
showed a curve similar to that of diprotic systems which suggests that the nitrogen atom of the Nmethyl group of the piperazine ring can also be protonated and also contributes to a shift in
equilibrium to the anti conformation.

Compound XIV Titration
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Figure 39. Graph depicting the percentage of the anti conformation of compound XIV present
as a function of pD

The pKaH1 for compound XIV is estimated to be about 7.0 according to the titration curve
shown in Figure 39 and the pKaH2 is estimated to be about 2.6. The reported pKaH1 and pKaH2 for
N-methylpiperazine are 9.1 and 4.6 respectively.53 Again, a decrease in the basicity of the
heterocyclic amine moiety is observed. It is also important to note, however, that the trend of the
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estimated pKaH values of compounds XII-XIV match the trend of the reported pKaH values of the
three heterocyclic amines (Figure 40).

Figure 40. Summary of the pKa trends of compounds XII-XIV and their free amine moieties
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To summarize, the three hybrid conformational switches show similar behavior in that they
all start out with a predominance of the anti conformation (60~66%) and all seem to reach a
maximum of 89~94% anti upon protonation. They also all behave similarly to compound I which
started at 66% and reached a maximum at 97 % anti. This leads us to believe that, if these
structures were to be incorporated into liposome structures, the liposomes would result in the early
leakage of contents and would thus not be able to serve as a viable pH-triggered liposomal drug
delivery system. In addition, we are able to show that the pKaH of these compounds can be
significantly altered by using different amine moieties.
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CHAPTER 4: CONCLUSIONS

Several amide-based flipid model compounds have been designed and synthesized. The
compounds studied include a flipid model consisting of long alkyl chain tails (I), structures that
include aromatic rings in the place of flipid tails (IV-VIII), and hybrid models that include one
alkyl chain tail and one heterocycle tail (XII-XIV). The products were confirmed by various 1HNMR techniques, and Direct Analysis in Real Time (DART) mass spectrometry.
The conformational equilibria of the amide compounds have also been studied by various
1

H-NMR techniques, including NOESY. For some of the models, (I & XII-XIV) the amide bond

had a relatively high rotational barrier which allowed for a rotation around the bond and an
interconversion between the syn and anti conformations that were slow enough to be captured as
separate structures by 1H-NMR. By identifying the peaks from the separate conformational
isomers and integrating their signals, we were able to compare the signal intensities and
successfully estimate a ratio between the two conformers. Unfortunately, all of these compounds
exhibited a predominance of the anti conformation, which would make the structures of this type
unsuitable for preparation of the conformationally switchable lipid-like components (flipids) for
liposomes.
The aryl rings compounds (IV-VIII) did not produce separate NMR peaks for the different
conformers and instead produced one average peak due to the fast interconversion of conformers
that occurs too rapidly for the NMR timescale. This is supported by data found in literature for
the calculated rotational barriers of similar aryl amide compounds and by our own NOESY studies.
These studies not only support the hypothesis that a rapid interconversion is occurring in solution,
but also suggest that there is still a predominance of the anti conformation. Due to the qualitative

75
nature of the NOESY technique, however, we are currently unable of establishing an accurate ratio
between the conformations as was done with the previous compounds.
The pH-sensitivity of the various amide compounds has been tested by 1H-NMR titration
studies. The addition of d-TFA successfully produced a shift in the equilibria further to the anti
conformation, which was observable and quantifiable by comparing the intensity of the 1H-NMR
peaks of the separate conformers. This allowed us to measure and plot the increase in the
percentage of the anti conformation present in solution as a function of pH. By varying the tertiary
amine moieties present in the tails of the model structures, we were able to determine how the
basicity and steric nature of the moieties affects the pH-sensitivity of the molecules. Interestingly,
although they have different tertiary amine groups, compounds I and XII-XIV seemed to behave
very similarly by starting out with a predominance of the anti isomer (60~66% anti) and all
reaching a maximum anti content of about 89~94%.
pKaH values were also estimated for compounds XII-XIV (pKaH 5.5, pKaH 7.5, pKaH1 7.0
and pKaH2 2.6 respectively) and the trend showed that the pH-sensitivity of these compounds can
be significantly altered by using different amine moieties. Even after the addition of the strong
acid d-TFA, there was no observable separation for the two conformers in bis-aryl compounds IVVIII. Therefore, it was not possible to establish accurate syn:anti ratios or conduct 1H-NMR
titration studies for these compounds.
The potential for compound I as a part of a pH-sensitive drug delivery system was tested
by incorporating it into the membrane of a liposome structure which encapsulated the
fluorophore/quencher pair ANTS/DPX. The liposomes were successfully formed, and their
diameter and surface charge were determined using a Dynamic Light Scattering (DLS) instrument.
A fluorimeter was then used to study the liposomal leakage of ANTS/DPX. However, the
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liposomes exhibited significant liposomal leakage before the addition of acid (pH ~8.5) and
showed only a slight increase in fluorescence after acid was added and even after the liposomes
were all effectively destroyed by the addition of a detergent. This suggests that the liposome
structures may already be unstable or the lipid/flipid molecules are not being tightly and uniformly
packed into the bilayer membranes. Although the hybrid models (XII-XIV) (containing both
cyclic and non-cyclic substituents at the amide bond) have not been incorporated into liposome
structures and tested for liposomal leakage, they behaved very similarly to compound I both in
their predominance of the anti conformation before treatment with acid and their pH-sensitivity
upon the addition of acid. Therefore, alkyl chain flipids like compound I need substantial
structural re-design and optimization in order to become a viable option for targeted drug delivery.
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CHAPTER 5: EXPERIMENTAL

5.1 Materials
The phospholipid 1-pamlitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and Npalmitoyl-sphingosine-1-(succinyl[methoxy(polyethylene glycol)2000]) (PEG) were purchased
from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). 8-aminonaphthalene-1,3,6-trisulfonic acid
disodium salt (ANTS) and p-xylene-bis-pyridinium bromide (DPX) were purchased from
Invitrogen-Molecular Probes (Eugene, OR, USA).

2-[4-(2-Hydroxyethyl)piperazin-1-yl]-

ethanesulfonic acid (HEPES) and the sodium chloride were purchased from Sigma Aldrich (St.
Louis, MO, USA). Octaethylene glycol monododecyl ether detergent was purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). The deuterated solvents were purchased from
Cambridge Isotope Laboratories (Tewksbury, MA, USA). All other solvents were purchased from
Fisher Scientific and were distilled by fractional distillation before use. 1H-NMR and 13C-NMR
were acquired by using a JEOL ECA 600 MHz FT-NMR spectrometer (Peabody, MA, USA).
High resolution mass spectra were acquired by using a JEOL Accu-TOF mass spectrometer (JEOL,
Peabody, MA, USA) equipped with a DART ionization source (IonSense, Saugus, MA, USA).
5.2 Conformational Analysis by NMR Spectroscopy
Samples of compounds I, IV-VIII, and XII-XIV (about 10 mg each) were dissolved in 0.6
µL of deuterated solvent (d-CHCl3 or d-MeOH) and analyzed by 1H-NMR,

13

C-NMR, 1H-1H

COSY, and 1H-13C HMQC. The % anti values reported in Chapter 3 are calculated from the 1HNMR spectra obtained from dissolving the samples in d-MeOH in order to remain consistent with
the titration studies which are conducted solely with d-MeOH. The % anti values were calculated
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by integrating the peaks from the separate conformers that correspond to the amide N-methyl
group protons and comparing the integration values to each other to establish a syn:anti ratio.
5.3 NMR Titration Studies
Compounds I and XII-XIV (about 10 mg each) were dissolved in 0.6 µL of deuterated
methanol and analyzed by 1H-NMR. For each spectrum, all of the peaks were identified and
integrated, and the syn:anti ratio was established and recorded as described in section 5.2. The
NMR samples were transferred to a small glass vial and their pH, or in this case, pD values were
determined through the use of a Fisher Scientific Orion Micro pH Electrode (Thermo Fisher
Scientific, Waltham, MA). Then, small volumes of a 1.0 mM solution of deuterated trifluoroacetic
acid (d-TFA) in d-MeOH were added to the samples using micropipettes. The vials were agitated
on a vortex to fully dissolve the acid in the d-MeOH, the new pD values were determined, and the
samples were transferred back into the same NMR tubes as before. Samples were analyzed by 1HNMR spectroscopy once again, the data was recorded, and the pD was measured a second time to
calculate an average pD value. The data was subsequently organized into tables. The % anti
values were calculated for each run using the calculated syn:anti ratios and plotted against the pD
in order to visualize the shift in the conformational equilibria of the compounds as a function of
acid concentration. d-TFA was added to the samples until the pD curve reached a plateau,
signifying that all or almost all of the compound had been protonated.
5.4 Synthesis of Fliposomes
Compound I was mixed with 1-pamlitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC).
N-palmitoyl-sphingosine-1-(succinyl[methoxy(polyethyleneglycol)2000])

(C16

PEG2000

Ceramide) was also added to the mixture to form a coating around the membrane for steric
stabilization of the liposome. Three sets of liposomes were prepared by mixing POPC, compound
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I, and PEG in molar ratios of 70:25:5, 45:50:5, 20:75:5, and 0:95:5 with agitation on a vortex in a
pH 8.5 aqueous solution of 50 mM ANTS/DPX solution, 5 mM HEPES buffer, and 145 mM
sodium chloride. The suspensions produced were frozen in -80 ºC EtOAc/liquid N2 bath and then
allowed to thaw and reach room temperature. This freeze/thaw cycle was repeated nine times in
order to allow the components to come together into proper liposome structures. These liposome
suspensions were subsequently extruded ten times to yield a homogeneous liposome formulation.
The extruded liposomes were purified with a Sephadex G-75 column (pH 8.5 buffer [5 mM HEPES,
145 mM NaCl]) and were subsequently analyzed with a Malvern Zeta 3000 dynamic light
scattering instrument (Malvern Instruments Ltd., Worcestershire, UK).
5.5 ANTS/DPX Leakage Assay
100 µL of the liposome suspensions obtained from the Sephadex column were dissolved
in 2.9 mL of pH 8.5 HEPES buffer (5 mM HEPES + 145 mM NaCl). Samples were tested for
fluorescence in cuvettes containing 50 µL aliquots of the samples dissolved in 2 mL of pH 8.5
HEPES buffer (5 mM HEPES + 145 mM NaCl). The fluorescence (λex = 350 nm, λem = 550 nm)
from ANTS was monitored on a QuantaMaster fluorometer (Photon Technology International,
Lawrenceville, NJ). Then, 20 µL of the detergent, octaethylene glycol mono-n-dodecyl ether,
were added to the samples at the end of each measurement.
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5.6 Synthesis of Compounds
5.6.1 Synthesis of Hexyl 4-methylbenzenesulfonate (II)

1-Hexanol (1.830 g, 14.68 mmol) was dissolved in chloroform (15.0 mL) and the resulting solution
was cooled down to 0 ºC by placing the reaction flask into an ice bath. Pyridine (2.360 mL, 29.30
mmol) was added to the mixture with stirring. Then, p-toluenesulfonyl chloride (4.200 g, 22.03
mmol) was added in small portions and the resulting mixture was stirred at 0 ºC for 2.5 h. The
solvent was subsequently removed by evaporation under reduced pressure and the residue was
dissolved in dichloromethane. The resulting solution was washed with 4 x 20.0 mL 1.0 M HCl
and 2 x 20.0 mL 2.0 M NaOH and was dried over anhydrous Na2SO4. The Na2SO4 salt was
removed via vacuum filtration and was rinsed with dichloromethane, then the excess solvent was
removed by rotary evaporation. The resulting residue was purified as a yellow-brown oil by
column chromatography (silica gel; Hexane : EtOAc, 39 : 1). Yield: 2.153 g (57.2 % yield). 1HNMR (600 MHz, CDCl3) δ 7.79 (dt, J = 8.4, 1.8 Hz, 2H, CH2), 7.34 (d, J = 7.9 Hz, 2H, CH2), 4.01
(t, J = 6.5 Hz, 2H, CH2), 2.45 (s, 3H, CH3), 1.62 (q, J = 6.6 Hz, 2H, CH2), 1.35-1.15 (m, 6H, CH2),
0.84 (t, J = 7.1 Hz, 3H, CH3).

13

C-NMR (150 MHz, CDCl3) δ 144.71 (CH2), 133.30 (CH2), 129.89

(CH2), 127.97 (CH2), 70.80 (CH2), 31.17 (CH2), 28.85 (CH2), 25.08 (CH2), 22.50 (CH2), 21.72
(CH2), 14.00 (CH3). HRMS: C13H20O3S calcd. m/z [M+H]+ 257.1206, found 257.1216.
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5.6.2 Synthesis of N-Hexyl-N,N’-dimethylethane-1,2-diamine (III)

N,N’-dimethylethylenediamine (0.970 mL, 9.01 mmol) was dissolved in acetonitrile (14.5 mL),
followed by the addition of K2CO3 salt (1.879 g, 13.60 mmol). The resulting suspension was
cooled to 0 ºC using an ice bath under stirring. Hexyl 4-methylbenzenesulfonate (II) (1.152 g,
4.494 mmol) was added to the reaction and the resulting mixture was stirred at 0 ºC for 24 h. The
K2CO3 salt was removed via vacuum filtration and the solvent was removed by rotary evaporation.
The residue was then dissolved in dichloromethane (10.0 mL) and the solution was washed with
2 x 5.0 mL H2O and dried over anhydrous Na2SO4. The Na2SO4 salt was removed via vacuum
filtration and was rinsed with dichloromethane. The residue was purified as a clear, pale-yellow
oil by column chromatography (silica gel; DCM : MeOH : Et3N, 9 : 1 : 0.1). Yield 220 mg (14.2 %).
1

H-NMR (600 MHz, CDCl3) δ 2.63 (t, J = 6.1 Hz, 2H, CH2N), 2.44 (t, J = 6.1 Hz, 2H, CH2N),

2.42 (s, 3H, CH3N), 2.30 (t, J = 7.2 Hz, 2H, CH2N), 2.18 (s, 3H, CH3N), 1.91 (bs, 1H, NH), 1.42
(quint, J = 7.2 Hz, 2H, CH2), 1.32-1.21 (m, 6H, CH2), 0.86 (t, J = 7.0 Hz, 3H, CH3). HRMS:
C10H24N2 calcd. m/z [M+H]+ 173.2012, found 173.2005.
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5.6.3 Synthesis of N-(2-(hexyl(methyl)amino)ethyl)-N-methyldecanamide (I)

N-Hexyl-N,N’-dimethylethane-1,2-diamine (III) (0.212 g, 1.23 mmol) was placed into a reaction
flask under argon atmosphere and was dissolved in dichloromethane (4.4 mL).

Then,

triethylamine (0.266 mL, 1.91 mmol) was added to the solution with stirring. The flask was
subsequently placed into an ice bath to lower the temperature to 0 ºC. Decanoic anhydride (0.649
g, 1.99 mmol) was slowly added to the solution in small portions with stirring. The reaction
mixture was allowed to slowly reach room temperature and was stirred for 20 h. The organic layer
was then washed with 3 x 2.5 mL aq. sat. Na2CO3 and dried over anhydrous Na2SO4. The Na2SO4
salt was removed via vacuum filtration and was rinsed with dichloromethane. The solvent was
then removed by rotary evaporation and the residue was purified as a clear, pale-yellow oil by
column chromatography (silica gel; DCM : MeOH, 9:1). Yield 331 mg (82.4 %). Rf: 0.52 (DCM :
MeOH, 9:1). 1H-NMR (600 MHz, CDCl3) δ 3.46 (t, J = 7.0 Hz, 2H, t-CH2N), 3.36 (t, J = 7.4 Hz,
2H, c-CH2N), 3.01 (s, 3H, t-CH3NC=O), 2.93 (s, 3H, c-CH3NC=O), 2.48 (t, J = 7.2 Hz, 2H, CH2),
2.37-2.26 (m, 4H, CH2), 2.25 (s, 3H, CH3N), 2.24 (s, 3H, CH3N), 1.62 (m, 2H, CH2), 1.43 (m, 2H,
CH2), 1.35-1.20 (m, 18H, CH2), 0.91-0.84 (4t, 6H, CH3).

C-NMR (150 MHz, CDCl3) δ 173.30,

13

173.10 (C=O), 58.46 (c-CH2), 58.18 (t-CH2), 55.88-54.92 (CH2), 48.51 (c-CH2), 45.90 (t-CH2),
42.77 (t-CH3), 42.48 (c-CH3), 36.20 (t-CH3), 33.99 (c-CH3), 33.70, 33.06 (CH2), 31.96 (CH2),
31.90 (CH2), 31.89 (CH2), 29.66 (CH2), 29.58 (CH2), 29.39 (CH2), 27.45 (CH2), 25.60 (CH2),
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25.16 (CH2), 22.75 (CH2), 22.72 (CH2), 14.19, 14.15 (CH3). HRMS: C20H42N2O calcd. m/z
[M+H]+ 327.3370, found 327.3357.

5.6.4 Synthesis of N-methyl-N-(pyridin-2-yl)benzamide (IV)

2-(methylamino) pyridine (1.020 mL, 9.923 mmol) was placed in a reaction flask under argon
atmosphere and dissolved in triethylamine (20.6 mL). The flask was placed into a water bath at
ambient temperature and benzoyl chloride (2.320 mL, 19.97 mmol) was added to the solution in a
dropwise fashion. The mixture was subsequently stirred overnight. The organic layer was then
washed with 3 x 5.0 mL 10 % aq. NH4Cl solution, 2 x 5.0 mL H2O, 1 x 5.0 mL 10 % aq. NaCl
solution, and then dried over anhydrous Na2SO4. The Na2SO4 salt was removed via vacuum
filtration and was rinsed with dichloromethane. Then, the product was purified as a yellow oil by
column chromatography (silica gel; Hexane : EtOAc, 2:1). Yield 700 mg (16.5 %). 1H-NMR (600
MHz, METHANOL-D4) δ 8.38 (dd, J = 4.9, 1.4 Hz, 1H, CH), 7.64 (td, J = 7.8, 1.9 Hz, 1H, CH),
7.33 (tt, J = 7.8, 1.2 Hz, 1H, p-CH), 7.29 (d, J = 7.0 Hz, 2H, o-CH), 7.24 (t, J = 7.2 Hz, 2H, mCH), 7.20 (dd, J = 7.4, 4.9 Hz, 1H, CH), 7.04 (d, J = 8.1 Hz, 1H, CH), 3.52 (s, 3H, CH3).

13

C-

NMR (150 MHz, METHANOL-D4) δ 171.80 (C=O), 156.54 (C), 148.44 (CH), 138.46 (CH),
135.86 (C), 130.08 (p-CH), 128.10 (o-CH), 127.86 (m-CH), 122.10 (CH), 121.90 (CH), 35.32
(CH3). HRMS: C13H12N2O calcd. m/z [M+H]+ 213.1022, found 213.1002.
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5.6.5 Synthesis of N-(4-methoxyphenyl)-N-methyl-4-nitrobenzamide (V)

4-methoxy-N-methylaniline (33 mg, 0.24 mmol) was dissolved in dichloromethane (1.800 mL) in
a reaction flask under argon atmosphere. The flask was placed in a water bath at ambient
temperature, and triethylamine (0.210 mL, 1.51 mmol) was added to the reaction flask with stirring.
p-Nitrobenzoyl chloride (92 mg, 0.50 mmol) was added to the solution dropwise and the mixture
was stirred overnight. The organic layer was subsequently washed with 3 x 5.0 mL 10 % aq.
NH4Cl solution, 2 x 5.0 mL H2O, 1 x 5.0 mL 10 % aq. NaCl solution, and then dried over
anhydrous Na2SO4. The Na2SO4 salt was removed via vacuum filtration and was rinsed with
dichloromethane. The residue was then isolated as yellow crystals, which were subsequently
recrystallized using methanol. Yield: 19 mg (28 %). 1H-NMR (600 MHz, METHANOL-D4) δ
8.06 (d, J = 8.4 Hz, 2H, CH), 7.49 (d, J = 8.5 Hz, 2H, CH), 7.08 (d, J = 8.7 Hz, 2H, CH), 6.80 (d,
J = 8.7 Hz, 2H, CH), 3.71 (s, 3H, CH3N), 3.45 (s, 3H, CH3O).

13

C-NMR (150 MHz, METHANOL-

D4) δ 169.55 (C=O), 158.96 (C), 147.99 (C), 142.56 (C), 136.29 (C), 129.16 (2 x CH), 128.40 (2
x CH), 122.68 (2 x CH), 114.30 (2 x CH), 54.53 (CH3), 37.27 (CH3). HRMS: C15H14N2O4 calcd.
m/z [M+H]+ 287.1026, found 287.1014.
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5.6.6 Synthesis of N-(4-methoxyphenyl)-4-nitrobenzamide (VI)

p-Anisidine (26 mg, 0.21 mmol) was dissolved in dichloromethane (1.620 mL) in a reaction flask
under argon atmosphere. The flask was placed in a water bath at ambient temperature, and
triethylamine (0.209 mL, 1.50 mmol) was added to the reaction flask followed by the addition of
p-Nitrobenzoyl chloride (92.5mg, 0.498 mmol) to the solution in small portions. The resulting
mixture was stirred overnight. The organic layer was then washed with 3 x 3.0 mL 10 % aq.
NH4Cl solution, 2 x 5.0 mL H2O, 1 x 5.0 mL 10 % aq. NaCl solution, and then dried over
anhydrous Na2SO4. The Na2SO4 salt was removed via vacuum filtration and was rinsed with
dichloromethane. The residue was then isolated as fluffy yellow crystals, which were subsequently
recrystallized using methanol. Yield: 15 mg (25 %). 1H-NMR (600 MHz, CDCl3) δ 8.33 (d, J =
8.7 Hz, 2H, CH), 8.03 (d, J = 8.7 Hz, 2H, CH), 7.85 (s, 1H, NH), 7.54 (d, J = 8.9 Hz, 2H, CH),
6.92 (d, J = 8.9 Hz, 2H, CH), 3.82 (s, 3H, CH3O).

13

C-NMR (150 MHz, CDCl3) δ 163.62 (C=O),

157.22 (C), 149.75 (C), 140.67 (C), 130.28 (C), 128.31 (2 x CH), 124.09 (2 x CH), 122.40 (2 x
CH), 114.45 (2 x CH), 55.61 (CH3O). HRMS: C14H12N2O4 calcd. m/z [M+H]+ 273.0870, found
273.0879.
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5.6.7 Synthesis of N-(4-(dimethylamino)phenyl)-N-methyl-4-nitrobenzamide (VII)

1-N,1-N,4-N-trimethylbenzene-1,4-diamine di-HCl salt (110 mg, 0.493 mmol) was dissolved in
dichloromethane (5.9 mL) in a reaction flask under argon atmosphere. The flask was placed in a
water bath at ambient temperature, and triethylamine (0.559 mL, 4.01 mmol) was added to the
reaction flask. Nitrobenzoyl chloride (186 mg, 1.00 mmol) was slowly added to the solution in
small portions and the mixture was stirred overnight. The organic layer was washed with 3 x 5.0
mL 1.0 M NaOH solution and then dried over anhydrous Na2SO4. The Na2SO4 salt was removed
via vacuum filtration and was rinsed with dichloromethane. The solvent was removed by rotary
evaporation and the residue was purified as a dark orange oil by column chromatography (silica
gel; Hexane : EtOAc, 1:1). Yield: 26 mg (17 %). 1H-NMR (600 MHz, METHANOL-D4) δ 8.05
(d, J = 8.8 Hz, 2H, CH), 7.49 (d, J = 8.8 Hz, 2H, CH), 6.96 (d, J = 8.9 Hz, 2H, CH), 6.58 (d, J =
8.9 Hz, 2H, CH), 3.43 (s, 3H, CH3NC=O), 2.86 (s, 6H, CH3N).

13

C-NMR (150 MHz,

METHANOL-D4) δ 170.96 (C=O), 151.14 (C), 149.19 (C), 144.24 (C), 133.50 (C), 130.46 (2 x
CH), 129.06 (2 x CH), 123.93 (2 x CH), 113.65 (2 x CH), 40.53 (2 x CH3N), 38.70 (CH3NC=O).
HRMS: C16H17N3O3 calcd. m/z [M+H]+ 300.1343, found 300.1318.
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5.6.8 Synthesis of N-(4-(dimethylamino)phenyl)-4-nitrobenzamide (VIII)

N,N-dimethyl-p-phenylenediamine (44 µL, 0.35 mmol) was dissolved in dichloromethane (2.510
mL) in a reaction flask under argon atmosphere. The flask was placed in a water bath at ambient
temperature, and triethylamine (0.293 mL, 2.10 mmol) was added to the reaction flask. pNitrobenzoyl chloride (130 mg, 0.701 mmol) was slowly added to the solution in small portions
and the mixture was stirred overnight. The organic layer was washed with 3 x 6.0 mL 10 % aq.
NH4Cl solution, 1 x 10.0 mL H2O, 1 x 5.0 mL 10 % aq. NaCl solution, and then dried over
anhydrous Na2SO4. The Na2SO4 salt was removed via vacuum filtration and was rinsed with
dichloromethane. Then, the solvent was removed by rotary evaporation and the residue was
isolated as dark red crystals, which were subsequently recrystallized using methanol. Yield: 31
mg (31 %). 1H-NMR (600 MHz, METHANOL-D4) δ 8.35 (d, J = 9.0 Hz, 2H, CH), 8.11 (d, J =
9.0 Hz, 2H, CH), 7.51 (d, J = 9.3 Hz, 2H, CH), 6.80 (d, J = 9.3 Hz, 2H, CH), 4.63 (s, 1H, NH),
2.93 (s, 6H, CH3). HRMS: C15H15N3O3 calcd. m/z [M+H]+ 286.1186, found 286.1190.
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5.6.9 Synthesis of Decanoyl chloride (IX)

Decanoic acid (0.906 g, 5.26 mmol) was dissolved in dichloromethane (6.8 mL) in a reaction flask
under argon atmosphere. Then, a 2.0 M solution of oxalyl chloride in dichloromethane (3.670 mL,
7.340 mmol) was added to the flask dropwise along with 2 drops of dimethylformamide. The
resulting solution was stirred at ambient temperature until the decanoic acid had completely
reacted, as monitored by Thin-Layer Chromatography (TLC), and the solvent was removed by
rotary evaporation. The residue was then dissolved in chloroform and the excess oxalyl chloride
was removed along with the chloroform through three consecutive simple distillations which
yielded a yellow-brown oil. The acid chloride product was used in the next step without further
purification or isolation.

5.6.10 Synthesis of N-(2-hydroxyethyl)-N-methyldecanamide (X)

2-(methylamino) ethanol (1.550 mL, 19.34 mmol) was dissolved in dichloromethane (10.0 mL) in
a reaction flask under argon atmosphere. The flask was cooled down to about -10 ºC by
submerging it into an acetone/ice bath. Then, decanoyl chloride (IX) (0.922 g, 4.81 mmol) was
dissolved in 2.000 mL of dichloromethane and the resulting solution was added to the reaction
mixture dropwise. The mixture was stirred for two hours. The organic layer was then washed

89
with 4 x 20.0 mL 10 % NH4Cl aq. solution and 2 x 20.0 mL Na2CO3 sat. aq. solution, and then
dried over anhydrous Na2SO4. The Na2SO4 salt was removed via vacuum filtration and was rinsed
with dichloromethane. The solvent was then removed by rotary evaporation and the residue was
purified as an orange oil by column chromatography (silica gel; EtOAc). Yield: 2.480 g (94.1%).
Rf: 0.25 (EtOAc).

1

H-NMR (600 MHz, METHANOL-D4) δ 3.65 (dt, J = 15.0, 5.4 Hz, 2H,

CH2NC=O), 3.46 (m, 2H, CH2OH), 3.09 (s, 3H, t-CH3NC=O), 2.92 (s, 3H, c-CH3NC=O), 2.38
(dt, J = 32.9, 7.6 Hz, 2H, CH2C=O), 1.58 (quint, J = 7.2 Hz, 2H, CH2), 1.38-1.21 (m, 12H, CH2),
0.87 (t, J = 7.2 Hz, 3H, CH3).

13

C-NMR (150 MHz, METHANOL-D4) δ 175.03, 174.77 (C=O),

59.41, 58.92 (CH2NC=O), 51.80, 50.23 (CH2OH), 36.21 (t-CH3NC=O), 33.09 (CH2C=O), 32.76
(c-CH3NC=O), 32.63 (CH2C=O), 31.70 (CH2), 29.36-29.02 (4 x CH2), 25.28, 24.90 (CH2), 22.38
(CH2), 13.09 (CH3). HRMS: C13H27NO2 calcd. m/z [M+H]+ 230.2115, found 230.2069.

5.6.11 Synthesis of N-(2-chloroethyl)-N-methyldecanamide (XI)

N-(2-hydroxyethyl)-N-methyldecanamide (X) (2.480 g, 10.81 mmol) was dissolved in chloroform
(24.8 mL) in a reaction flask under argon atmosphere. Thionyl chloride (0.902 mL, 12.4 mmol)
was added to the flask with stirring and the mixture was allowed to reflux for 30 minutes. The
excess thionyl chloride was removed along with the chloroform by three consecutive simple
distillation cycles and yielded a yellow oil. The product was then used in the following reactions
without further purification.
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5.6.12 Synthesis of N-methyl-N-(2-morpholinoethyl)decanamide (XII)

N-(2-chloroethyl)-N-methyldecanamide (XI) (0.199 g, 0.802 mmol) was dissolved in
dichloromethane (2.000 mL) in a reaction flask under argon atmosphere. Then, pyridine (0.259
mL, 3.22 mmol) was added to the solution with stirring, followed by the addition of morpholine
(0.173 mL, 2.00 mmol) dropwise. The resulting mixture was allowed to reflux overnight and the
organic layer was washed with 3 x 3.0 mL NH4Cl aq. solution and then dried over anhydrous
Na2SO4. The Na2SO4 salt was removed via vacuum filtration and was rinsed with dichloromethane,
which was then removed by rotary evaporation. The residue was purified as a brown oil by column
chromatography (silica gel; EtOAc). Yield: 153 mg (60.0 %). Rf: 0.60 (DCM : MeOH, 9:1). 1HNMR (600 MHz, METHANOL-D4) δ 3.68 (2d, 4H, CH2N), 3.51 (t, 2H, CH2NC=O), 3.07 (s, 3H,
t-CH3NC=O), 2.94 (s, 3H, c-CH3NC=O), 2.57-2.48 (m, 6H, CH2O + CH2N), 2.39 (2t, J = 7.8 Hz,
2H, CH2C=O), 1.60 (quint, J = 7.2 Hz, 2H, CH2), 1.39-1.24 (m, 12H, CH2), 0.90 (t, J = 7.2 Hz,
3H, CH3).

C-NMR (150 MHz, METHANOL-D4) δ 174.53, 174.46 (C=O), 66.54 (CH2N), 66.47

13

(CH2N), 56.39, 55.34 (CH2N), 53.76 (CH2O), 53.51 (CH2O), 47.05, 44.24 (CH2NC=O), 35.13 (tCH3NC=O), 33.02 (c-CH3NC=O), 32.46 (CH2C=O), 29.30 (CH2), 29.24 (CH2), 29.19 (CH2),
29.08 (CH2), 25.30 (CH2), 24.98 (CH2), 22.39 (CH2), 13.10 (CH3). HRMS: C17H34N2O2 calcd.
m/z [M+H]+ 299.2693, found 299.2646.
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5.6.13 Synthesis of N-methyl-N-(2-(piperidin-1-yl)ethyl)decanamide (XIII)

N-(2-chloroethyl)-N-methyldecanamide (XI) (0.199 g, 0.802 mmol) was dissolved in
dichloromethane (1.840 mL) in a reaction flask under argon atmosphere. Then, pyridine (0.286
mL, 3.55 mmol) was added to the solution with stirring, followed by the addition of piperidine
(0.198 mL, 2.00 mmol) dropwise. The resulting mixture was allowed to reflux overnight and the
organic layer was washed with 3 x 1.0 mL 0.01 M HCl aq. solution and then dried over anhydrous
Na2SO4. The Na2SO4 salt was removed via vacuum filtration and was rinsed with dichloromethane,
which was then removed by rotary evaporation. The residue was isolated as bright yellow crystals.
Yield: 147 mg (59.1 %). Rf: 0.47 (DCM : MeOH, 9:1). 1H-NMR (600 MHz, METHANOL-D4)
δ 3.50 (m, J = 6.2 Hz, 4H, CH2N), 3.11 (s, 3H, t-CH3NC=O), 3.06 (s, 3H, c-CH3NC=O), 2.41 (m,
12H, 3 x CH2 + 2 x CH2N + CH2C=O), 1.61 (quint, J = 7.2 Hz, 2H, CH2), 1.41-1.24 (m, 12H,
CH2), 0.90 (t, J = 7.0 Hz, 3H, CH3).

13

C-NMR (150 MHz, METHANOL-D4) δ 174.5, 174.41

(C=O), 56.48 (CH2C=O), 54.59 (CH2NC=O), 54.29 (CH2N), 44.62 (2 x CH2N), 36.20 (tCH3NC=O), 35.16 (c-CH3NC=O), 33.09 (CH2), 33.02 (CH2), 32.97 (CH2), 31.71 (CH2), 29.29
(CH2), 29.08 (CH2), 25.25 (CH2), 24.93 (CH2), 23.79 (CH2), 22.39 (CH2), 13.09 (CH3). HRMS:
C18H36N2O calcd. m/z [M+H]+ 297.2900, found 297.2851.

92
5.6.14 Synthesis of N-methyl-N-(2-(4-methylpiperazin-1-yl)ethyl)decanamide (XIV)

N-(2-chloroethyl)-N-methyldecanamide (XI) (0.199 g, 0.802 mmol) was dissolved in
dichloromethane (1.840 mL) in a reaction flask under argon atmosphere. Then, pyridine (0.286
mL, 3.55 mmol) was added to the solution with stirring, followed by the addition of Nmethylpiperazine (0.223 mL, 2.01 mmol) dropwise. The resulting mixture was allowed to reflux
overnight and the organic layer was washed with 3 x 1.0 mL 10% NH4Cl aq. solution and then
dried over anhydrous Na2SO4. The Na2SO4 salt was removed via vacuum filtration and was rinsed
with excess dichloromethane. The solvent was removed by rotary evaporation and the residue was
purified as a thick yellow oil by column chromatography (silica gel; DCM : MeOH, 8:2). Yield:
88 mg (35.1%). Rf: 0.29 (DCM : MeOH, 8:2). 1H-NMR (600 MHz, METHANOL-D4) δ 3.51
(dt, J = 16.2, 7.2 Hz, 2H, CH2NC=O), 3.06 (s, 3H, t-CH3NC=O), 2.93 (s, 3H, c-CH3NC=O), 2.852.45 (m, 10H, CH2N), 2.43-2.34 (m, 5H, CH2C=O + CH3N), 1.59 (quint, J = 7.2 HZ, 2H, CH2),
1.39-1.25 (m, 12H, CH2), 0.90 (t, J = 7.2 Hz, 3H, CH3).

13

C-NMR (150 MHz, METHANOL-D4)

δ 174.50 (C=O), 55.66 (CH2N), 54.57 (CH2N), 54.39 (CH2N), 54.22 (2 x CH2N), 44.45 (t-CH3N),
44.28 (CH2NC=O), 44.06 (c-CH3N), 35.10 (t-CH3NC=O), 33.02 (c-CH3NC=O), 32.46 (CH2C=O),
31.71 (CH2), 29.31 (CH2), 29.25 (CH2), 29.10 (CH2), 25.31 (CH2), 24.98 (CH2), 22.39 (CH2),
13.10 (CH3). HRMS: C18H37N3O calcd. m/z [M+H]+ 312.3009, found 312.2941.
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Compound I: 1H-NMR, CDCl3

APPENDIX A: SELECTED 1H-NMR SPECTRA
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Compound X: 1H-NMR, CD3OD
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Compound XII: 1H-NMR, CD3OD
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Compound XIII: 1H-NMR, CD3OD
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Compound XIV: 1H-NMR, CD3OD
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Compound I: 13C-NMR, CDCl3

APPENDIX B: SELECTED 13C-NMR SPECTRA
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Compound XII: 13C-NMR, CD3OD
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Compound XIII: 13C-NMR, CD3OD
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Compound XIV: 13C-NMR, CD3OD
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Compound I: 1H-1H NMR, CDCl3

APPENDIX C: SELECTED 1H-1H COSY SPECTRA

Compound IV: 1H-1H NMR, CD3OD
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Compound V: 1H-1H NMR, CD3OD
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Compound VI: 1H-1H NMR, CDCl3
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Compound VII: 1H-1H NMR, CD3OD
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Compound VIII: 1H-1H NMR, CD3OD
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Compound X: 1H-1H NMR, CD3OD
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Compound XII: 1H-1H NMR, CD3OD
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Compound XIII: 1H-1H NMR, CD3OD
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Compound XIV: 1H-1H NMR, CD3OD
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Compound I: 1H-13C NMR, CDCl3

APPENDIX D: SELECTED 1H-13C HMQC SPECTRA

Compound IV: 1H-13C NMR, CD3OD
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Compound V: 1H-13C NMR, CD3OD
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Compound VI: 1H-13C NMR, CDCl3
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Compound VII: 1H-13C NMR, CD3OD
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Compound X: 1H-13C NMR, CD3OD
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Compound XII: 1H-13C NMR, CD3OD
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Compound XIII: 1H-13C NMR, CD3OD
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Compound XIV: 1H-13C NMR, CD3OD
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APPENDIX E: SELECTED 1H-NMR TITRATION DATA
Table 1
Titration Data for Compound I
TFA*
Added
(µL)
0.00

Total
TFA
(µL)
0.00

TFA:Flipid
Molar Ratio

Average
pH

T
(3.062 ppm)

C
(2.925 ppm)

% anti

0.0 : 1.0

8.22

1.95

0.99

66.3%

7.00

7.00

0.2 : 1.0

8.07

1.92

0.97

66.4%

10.00

17.00

0.5 : 1.0

7.89

2.01

0.90

69.1%

7.00

24.00

0.7 : 1.0

7.74

2.04

0.88

69.9%

7.00

31.00

0.9 : 1.0

7.65

2.07

0.87

70.4%

10.00

41.00

1.2 : 1.0

7.60

2.12

0.81

72.4%

14.00

55.00

1.6 : 1.0

7.42

2.20

0.73

75.1%

14.00

69.00

2.0 : 1.0

7.14

2.31

0.62

78.8%

14.00

83.00

2.5 : 1.0

6.73

2.57

0.36

87.7%

14.00

97.00

2.9 : 1.0

5.82

2.80

0.13

95.6%

14.00

111.00

3.3 : 1.0

2.80

2.83

0.10

96.6%

*TFA refers to a 1.0 mM solution of deuterated TFA in d-MeOH
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Table 6
Titration Data for Compound XII
d-TFA*
Added
(µL)
0.00

Total
d-TFA*
(µL)
0.00

TFA:Flipid
Molar
Ratio
0.0 : 1.0

Average
pH

T
(3.072 ppm)

C
(2.935 ppm)

% anti

6.79

1.88

0.99

65.5%

0.00

0.00

0.0 : 1.0

6.75

1.85

0.98

65.4%

9.00

9.00

0.2 : 1.0

6.17

1.90

0.94

66.9%

18.00

18.00

0.5 : 1.0

5.95

1.92

0.89

68.3%

18.00

27.00

0.7 : 1.0

5.76

1.97

0.82

70.6%

18.00

36.00

1.0 : 1.0

5.66

2.04

0.81

71.6%

18.00

45.00

1.2 : 1.0

5.61

2.06

0.79

72.3%

18.00

54.00

1.5 : 1.0

5.47

2.12

0.73

74.4%

18.00

63.00

1.7 : 1.0

5.34

2.31

0.54

81.1%

18.00

72.00

2.0 : 1.0

5.26

2.33

0.52

81.8%

18.00

81.00

2.2 : 1.0

5.07

2.41

0.44

84.6%

18.00

90.00

2.4 : 1.0

4.87

2.45

0.40

86.0%

18.00

99.00

2.7 : 1.0

3.64

2.64

0.21

92.6%

18.00

108.00

2.9 : 1.0

3.16

2.64

0.21

92.6%

18.00

117.00

3.2 : 1.0

2.60

2.64

0.21

92.6%

20.00

128.00

3.5 : 1.0

2.49

2.64

0.21

92.6%

20.00

137.00

3.7 : 1.0

2.22

2.64

0.21

92.6%

20.00

148.00

4.0 : 1.0

2.21

2.64

0.21

92.6%

*TFA refers to a 1.0 mM solution of deuterated TFA in d-MeOH

Two NMR samples were used simultaneously for this titration in order to increase
efficiency. As one sample (gray rows in Table 6) was being analyzed by NMR, the second sample
(white rows in Table 6) was being prepared by adding the appropriate amount of d-TFA.
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Table 7
Titration Data for Compound XIII
d-TFA*
Added
(µL)
0.00

Total
d-TFA*
(µL)
0.00

TFA:Flipid
Molar
Ratio
0.0 : 1.0

Average
pH

T
(3.061 ppm)

C
(2.922 ppm)

% anti

9.40

1.74

1.08

61.7%

0.00

0.00

0.0 : 1.0

9.50

1.78

1.12

61.4%

7.00

7.00

0.2 : 1.0

8.60

1.81

1.09

62.4%

13.50

13.50

0.4 : 1.0

8.15

1.89

0.93

67.0%

13.50

20.50

0.6 : 1.0

8.08

1.93

0.93

67.5%

13.50

27.00

0.8 : 1.0

7.86

Overlap

Overlap

N/A

13.50

34.00

1.0 : 1.0

7.72

2.06

0.79

72.3%

13.50

40.50

1.2 : 1.0

7.58

2.11

0.78

73.0%

13.50

47.50

1.4 : 1.0

7.45

Overlap

Overlap

N/A

13.50

54.00

1.6 : 1.0

7.36

2.37

0.52

82.0%

13.50

61.00

1.8 : 1.0

7.15

2.47

0.42

85.5%

13.50

67.50

2.0 : 1.0

7.07

2.48

0.41

85.8%

13.50

74.50

2.2 : 1.0

6.62

Overlap

Overlap

N/A

13.50

81.00

2.4 : 1.0

6.43

2.64

0.25

91.3%

10.50

85.00

2.5 : 1.0

5.82

2.61

0.25

91.3%

7.00

88.00

2.6 : 1.0

3.40

2.57

0.32

88.9%

*TFA refers to a 1.0 mM solution of deuterated TFA in d-MeOH

Two NMR samples were used simultaneously for this titration in order to increase
efficiency. As one sample (gray rows in Table 7) was being analyzed by NMR, the second sample
(white rows in Table 7) was being prepared by adding the appropriate amount of d-TFA.
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Table 8
Titration Data for Compound XIV
d-TFA*
Added
(µL)
0.00

Final dTFA*
(µL)
0.00

TFA:Flipid
Molar Ratio

Average
pH

T
(3.062 ppm)

C
(2.928 ppm)

% anti

1 : 0.00

8.24

1.79

0.99

64.4%

0.00

0.00

1 : 0.00

7.89

1.81

0.98

64.9%

8.00

8.00

1 : 0.25

7.73

1.79

0.96

65.1%

16.00

16.00

1 : 0.50

7.46

1.83

0.96

65.6%

16.00

24.00

1 : 0.75

7.30

1.90

0.94

66.9%

16.00

32.00

1 : 1.00

7.21

1.91

0.92

67.5%

16.00

40.00

1 : 1.25

7.05

1.94

0.89

68.6%

16.00

48.00

1 : 1.50

6.77

1.99

0.81

71.1%

16.00

56.00

1 : 1.75

6.76

2.05

0.75

73.2%

16.00

64.00

1 : 2.00

6.47

Overlap

Overlap

N/A

16.00

72.00

1 : 2.25

6.33

2.08

0.72

74.3%

16.00

80.00

1 : 2.50

5.94

2.10

0.70

75.0%

16.00

88.00

1 : 2.75

4.88

2.12

0.68

75.7%

16.00

96.00

1 : 3.00

3.51

2.21

0.59

78.9%

16.00

104.00

1 : 3.25

3.21

2.28

0.52

81.4%

16.00

112.00

1 : 3.50

3.03

2.35

0.45

83.9%

16.00

120.00

1 : 3.75

2.89

2.39

0.41

85.4%

16.00

128.00

1 : 4.00

2.70

2.41

0.39

86.1%

16.00

136.00

1 : 4.25

2.57

2.47

0.33

88.2%

16.00

144.00

1 : 4.50

2.46

2.49

0.31

88.9%

16.00

152.00

1 : 4.75

2.37

2.51

0.29

89.6%

16.00

160.00

1 : 5.00

2.31

2.52

0.28

90.0%

16.00

168.00

1 : 5.25

2.25

2.54

0.26

90.7%

16.00

176.00

1 : 5.50

2.24

2.55

0.25

91.1%

16.00

184.00

1 : 5.75

2.19

2.57

0.23

91.8%

16.00

192.00

1 : 6.00

2.15

2.58

0.22

92.1%

100.00

284.00

1 : 8.85

1.69

2.62

0.18

93.6%

*TFA refers to a 1.0 mM solution of deuterated TFA in d-MeOH
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Two NMR samples were used simultaneously for this titration in order to increase
efficiency. As one sample (gray rows in Table 8) was being analyzed by NMR, the second sample
(white rows in Table 8) was being prepared by adding the appropriate amount of d-TFA.
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Compound I: DART Ion Source

APPENDIX F: SELECTED MASS SPECTRA

Compound II: DART Ion Source
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Compound III: DART Ion Source
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Compound IV: DART Ion Source
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Compound V: DART Ion Source
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Compound VI: DART Ion Source
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Compound VII: DART Ion Source
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Compound VIII: DART Ion Source
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Compound X: DART Ion Source
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Compound XII: DART Ion Source
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Compound XIII: DART Ion Source
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Compound XIV: DART Ion Source
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